Filter
353
Filtered Results: 353
Text search:
National
Drug
Authority,
Uganda
Featured
Recommendations
28
New Publications
119
Language
Document type
No document type
208
Studies & Reports
77
Guidelines
34
Strategic & Response Plan
15
Manuals
9
Fact sheets
5
Situation Updates
3
Training Material
2
Countries / Regions
Uganda
68
Kenya
26
Malawi
12
Tanzania
12
Ethiopia
12
Global
11
Nigeria
9
South Africa
9
Zambia
9
Ghana
8
Rwanda
8
Africa
8
Congo, Democratic Republic of
8
Liberia
8
Sierra Leone
7
Namibia
4
Zimbabwe
3
Guinea
3
Syria
2
Iran
2
Senegal
2
Jordan
2
Sudan
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Mexico
1
Lesotho
1
Benin
1
Cameroon
1
Albania
1
Laos
1
Burkina Faso
1
Morocco
1
Philippines
1
Haiti
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Germany
1
Saudi Arabia
1
West and Central Africa
1
Western and Central Europe
1
Gabon
1
Tunisia
1
Lebanon
1
Sri Lanka
1
Greece
1
Georgia
1
Central African Republic
1
Botswana
1
South Sudan
1
Iraq
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
155
Clinical Guidelines
31
Public Health
19
Women & Child Health
15
Key Resources
10
Pharmacy & Technologies
10
Capacity Building
4
Toolboxes
HIV
45
AMR
35
Mental Health
25
Pharmacy
20
TB
16
NTDs
12
Ebola
10
Rapid Response
9
Refugee
9
COVID-19
7
Planetary Health
7
Caregiver
6
NCDs
6
Disability
4
Conflict
4
Global Health Education
3
Cholera
2
Health Financing Toolbox
2
Zika
2
Natural Hazards
1
Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPC published here describes the characteristics of new types of insecticide-treated nets (ITNs) to control malaria transmission in areas with insecticide-resist...
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
A feasibility study in five African sites
Project Paper to provide an additional grant for: Human Development Systems Strengthening Project (HDSSP)(P145965, H9360)
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
